Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population

Raj Vardhan Azad; Mansur Ali Khan; Bhuvan Chanana; Shorya Azad

首页> 外文期刊>Japanese Journal of Ophthalmology >Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population

【24h】

Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population

机译：玻璃体腔注射贝伐单抗治疗继发于印度人群中与年龄相关的黄斑变性继发性小凹脉络膜新生血管

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose To investigate the 6-month safety profile and clinical outcomes of intravitreal bevacizumab for treating subfoveal choroidal neovascularization (CNV) in age-related macular degeneration (AMD).

机译：目的探讨玻璃体内贝伐单抗治疗年龄相关性黄斑变性（AMD）的小凹下脉络膜新生血管（CNV）的6个月安全性和临床结果。

著录项

来源
《Japanese Journal of Ophthalmology》 |2008年第1期|p.52-56|共5页
作者
Raj Vardhan Azad; Mansur Ali Khan; Bhuvan Chanana; Shorya Azad;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population. [J] . Azad RV, Khan MA, Chanana B, Japanese Journal of Ophthalmology . 2008,第1期

机译：玻璃体内贝伐单抗用于继发于印度人群中与年龄相关的黄斑变性继发性小凹下脉络膜新生血管。
2. Comparing outcomes in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration treated with two different doses of primary intravitreal bevacizumab: results of the Pan-American Collaborative Retina Study Group (PA [J] . Japanese Journal of Ophthalmology . 2009,第2期

机译：比较两种不同剂量的玻璃体内贝伐单抗治疗年龄相关性黄斑变性继发于黄斑变性的小凹脉络膜新生血管的结果：泛美视网膜研究小组（PA）的结果
3. Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration: a 12-month follow-up study. [J] . Costagliola C, Romano M, Corte MD Retina . 2009,第9期

机译：玻璃体腔注射贝伐单抗治疗未治疗的继发于年龄相关性黄斑变性的小凹下隐匿性脉络膜新生血管的患者：一项为期12个月的随访研究。
4. Transpupillary thermotherapy for the treatment of choroidal neovascularization in age-related macular degeneration [C] . Chang-Hao Yang, Tzu-Hsun Tsai, Chung-May Yang, . 2004

机译：经瞳孔热疗法治疗年龄相关性黄斑变性的脉络膜新生血管
5. The role of bone morphogenetic protein 4 in the pathogenesis of choroidal neovascularization in age-related macular degeneration. [D] . Xu, Jing. 2011

机译：骨形态发生蛋白4在年龄相关性黄斑变性中脉络膜新生血管形成的发病机理中的作用。
6. Combined therapy (intravitreal bevacizumab plus verteporfin photodynamic therapy) versus intravitreal bevacizumab monotherapy for choroidal neovascularization due to age-related macular degeneration: a 1-year follow-up study [O] . Sandro Saviano, Pia Easter Leon, Alessandro Mangogna, 2016

机译：联合治疗（玻璃体内贝伐单抗加维替泊芬光动力疗法）与玻璃体内贝伐单抗单药治疗年龄相关性黄斑变性引起的脉络膜新生血管：一项为期一年的随访研究
7. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration [O] . Claudio Furino, Francesco Boscia, Nicola Recchimurzo, 2009

机译：用于治疗的玻璃体内贝伐单抗治疗 - 幼苗骨科隐匿性脑膜脉络膜新生血管形成在年龄相关的黄斑变性

Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population

摘要

著录项

相似文献

相关主题

期刊订阅